Dihydroxybenzisoxazolin-3-yl-substituted-5-nitroimidazoles as
申请人:Merck & Co., Inc.
公开号:US04144345A1
公开(公告)日:1979-03-13
Dihydroxybenzisoxazolin-3-yl-substituted-1-methyl-5-nitroimidazoles having the hydroxy- groups on adjacent 4,5-; 5,6- or 6,7-positions of the isoxazolin group. These compounds have antibacterial and antiprotozoal activity in humans and animals. They are particularly active against trypanosomiasis and trichomoniasis.